We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: The A7 Agar enables the culture, semi-quantitative enumeration and the morphological identification (solid method) of Ureaplasma urealyticum and Mycoplasma hominis (Typical “fried egg” appearance”(Photo courtesy of the ELITech Group).

Antibacterial Resistance Revealed in Women with UTIs

Nearly 20% of women aged 15-29 are diagnosed with a urinary tract infection (UTI) and antibiotic resistance prolongs UTI treatment and resistance profiles vary regionally. This regional variation is an important consideration in guiding empirical treatment selection. More...
08 Sep 2017
Image: Researchers have identified biomarkers in the blood that are a promising target for a potential new test to diagnose a recent ischemic stroke (Photo by MNT).

Molecular Blood Test Could Diagnose Ischemic Stroke

Ischemic strokes, the most common and deadliest form of stroke, are caused when the contents of plaque in a major artery break away, forming a clot and blocking blood flow to the brain. More...
07 Sep 2017
Image: The AU480 is the ideal main clinical chemistry analyzer for small- to medium-sized laboratories (Photo courtesy of Beckman Coulter).

Side Effects of BP Drugs Genetically Determined

Thiazide diuretics are one of the most widely used and effective class of medications used to treat high blood pressure, and is highly effective at preventing heart attacks and strokes in patients with hypertension. More...
07 Sep 2017
Image: The NanoDrop 1000 spectrophotometer used for quantification and purity assessment of RNA samples (Photo courtesy of Thermo Fisher Scientific).

Blood Test Predicts Prostate Tumor Resistance

Prostate cancer (PCa) is the most common cancer and the third leading cause of cancer death among European men. In metastatic PCa progression from a hormone-sensitive state to castration resistance under androgen deprivation therapy marks the transition to the lethal phenotype of the disease. More...
07 Sep 2017
Image: A diagram for the basis of the MedOncAlyzer 170 panel (Photo courtesy of Exosome Diagnostics).

Liquid Biopsy Panel Yields Complete Molecular Profile

The first liquid biopsy pan-cancer panel that simultaneously interrogates exosomal ribonucleic acid (exoRNA) and circulating tumor DNA (ctDNA) in a single assay has been launched. More...
06 Sep 2017

Novel PCR Test Detects H. Pylori Drug Resistance

An estimated one million new cases of gastric cancer and 720,000 gastric cancer related deaths occur worldwide each year. Helicobacter pylori is a Group 1 carcinogen that is responsible for approximately 89% of lower stomach gastric cancer cases. More...
06 Sep 2017
Image: A newly developed molecular test could detect Alzheimer\'s disease at a pre-symptomatic state. The results indicated that multivariate analysis of transcripts in blood samples can provide an accurate and minimally invasive strategy for diagnosis of AD and early detection of AD risk (Image courtesy of Arizona State University; Graphic by Jason Drees).

Molecular Blood Test Could Identify Alzheimer's

A new multivariate molecular test is being developed that includes testing for genes to identify people at risk of developing Alzheimer’s disease (AD) and testing of peripheral blood leukocyte RNA transcripts to provide early diagnosis of people with AD. The new method distinguished between Alzheimer’s, Parkinson’s, and healthy controls, indicating that it can pick out AD from other degenerative brain conditions. More...
06 Sep 2017
New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
All-in-One Molecular System
AIO M160
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.